

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.40379600 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.40379600 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.11589793 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.11589793 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.88849094 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.38390811 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.38390811 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.38390811 |
| 9 | glyoxylate metabolic process (GO:0046487) | 6.27699142 |
| 10 | cysteine metabolic process (GO:0006534) | 6.14519793 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.07888543 |
| 12 | tryptophan metabolic process (GO:0006568) | 6.03216765 |
| 13 | lysine metabolic process (GO:0006553) | 5.82905122 |
| 14 | lysine catabolic process (GO:0006554) | 5.82905122 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.71999905 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40465522 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.38867164 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.38450335 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.34892247 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.27638314 |
| 21 | homocysteine metabolic process (GO:0050667) | 5.10032002 |
| 22 | urate metabolic process (GO:0046415) | 5.05606462 |
| 23 | urea cycle (GO:0000050) | 5.04062353 |
| 24 | urea metabolic process (GO:0019627) | 5.04062353 |
| 25 | aromatic amino acid family metabolic process (GO:0009072) | 5.01309405 |
| 26 | drug transmembrane transport (GO:0006855) | 5.00259316 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 4.97582449 |
| 28 | bile acid metabolic process (GO:0008206) | 4.86829304 |
| 29 | alpha-amino acid catabolic process (GO:1901606) | 4.73236549 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.67941098 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 4.63888394 |
| 32 | regulation of meiosis I (GO:0060631) | 4.63413292 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.61673401 |
| 34 | drug catabolic process (GO:0042737) | 4.61480179 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.61398185 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.55810836 |
| 37 | protein carboxylation (GO:0018214) | 4.55810836 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.53968657 |
| 39 | indolalkylamine metabolic process (GO:0006586) | 4.52523920 |
| 40 | serine family amino acid metabolic process (GO:0009069) | 4.52483832 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.52326631 |
| 42 | cellular amino acid catabolic process (GO:0009063) | 4.45801590 |
| 43 | regulation of protein activation cascade (GO:2000257) | 4.43070629 |
| 44 | short-chain fatty acid metabolic process (GO:0046459) | 4.41259548 |
| 45 | cellular modified amino acid catabolic process (GO:0042219) | 4.41171882 |
| 46 | regulation of fibrinolysis (GO:0051917) | 4.40871867 |
| 47 | glutamate metabolic process (GO:0006536) | 4.40476259 |
| 48 | amine catabolic process (GO:0009310) | 4.40003250 |
| 49 | cellular biogenic amine catabolic process (GO:0042402) | 4.40003250 |
| 50 | benzene-containing compound metabolic process (GO:0042537) | 4.25514717 |
| 51 | drug transport (GO:0015893) | 4.22505876 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.21027102 |
| 53 | ethanol oxidation (GO:0006069) | 4.19873228 |
| 54 | exogenous drug catabolic process (GO:0042738) | 4.18953943 |
| 55 | serine family amino acid biosynthetic process (GO:0009070) | 4.17862334 |
| 56 | glycine metabolic process (GO:0006544) | 4.17742434 |
| 57 | cellular glucuronidation (GO:0052695) | 4.17281667 |
| 58 | regulation of complement activation (GO:0030449) | 4.16360508 |
| 59 | aspartate family amino acid catabolic process (GO:0009068) | 4.16318567 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.15530909 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.15530909 |
| 62 | regulation of triglyceride catabolic process (GO:0010896) | 4.12178722 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.10384152 |
| 64 | acetyl-CoA metabolic process (GO:0006084) | 4.09506290 |
| 65 | regulation of cholesterol esterification (GO:0010872) | 4.06468392 |
| 66 | aldehyde catabolic process (GO:0046185) | 4.05583734 |
| 67 | reverse cholesterol transport (GO:0043691) | 4.05082792 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 4.04617221 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 4.04617221 |
| 70 | macromolecular complex remodeling (GO:0034367) | 4.04617221 |
| 71 | ketone body metabolic process (GO:1902224) | 4.01166244 |
| 72 | acylglycerol homeostasis (GO:0055090) | 4.00647368 |
| 73 | triglyceride homeostasis (GO:0070328) | 4.00647368 |
| 74 | 2-oxoglutarate metabolic process (GO:0006103) | 3.99572729 |
| 75 | organic acid catabolic process (GO:0016054) | 3.98957151 |
| 76 | carboxylic acid catabolic process (GO:0046395) | 3.98957151 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 3.98544691 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93925934 |
| 79 | fatty acid oxidation (GO:0019395) | 3.92016653 |
| 80 | lipid oxidation (GO:0034440) | 3.84869099 |
| 81 | carnitine metabolic process (GO:0009437) | 3.84706746 |
| 82 | valine metabolic process (GO:0006573) | 3.81351807 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.81118987 |
| 84 | glucuronate metabolic process (GO:0019585) | 3.81118987 |
| 85 | monocarboxylic acid catabolic process (GO:0072329) | 3.80462570 |
| 86 | fatty acid catabolic process (GO:0009062) | 3.74304609 |
| 87 | arginine metabolic process (GO:0006525) | 3.73450690 |
| 88 | phospholipid efflux (GO:0033700) | 3.72404471 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.71374398 |
| 90 | proteasome assembly (GO:0043248) | 3.67668503 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.65484590 |
| 92 | plasma lipoprotein particle clearance (GO:0034381) | 3.65115174 |
| 93 | response to mercury ion (GO:0046689) | 3.62854983 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 3.60380425 |
| 95 | mitotic metaphase plate congression (GO:0007080) | 3.59932423 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.53145246 |
| 97 | drug metabolic process (GO:0017144) | 3.51781800 |
| 98 | branched-chain amino acid metabolic process (GO:0009081) | 3.50079937 |
| 99 | branched-chain amino acid catabolic process (GO:0009083) | 3.49775089 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.48667137 |
| 101 | response to nitrosative stress (GO:0051409) | 3.46854258 |
| 102 | cofactor catabolic process (GO:0051187) | 3.45169697 |
| 103 | very long-chain fatty acid metabolic process (GO:0000038) | 3.42728595 |
| 104 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.41663634 |
| 105 | cullin deneddylation (GO:0010388) | 3.25396613 |
| 106 | regulation of DNA methylation (GO:0044030) | 3.24667010 |
| 107 | protein localization to kinetochore (GO:0034501) | 3.18736497 |
| 108 | protein localization to chromosome, centromeric region (GO:0071459) | 3.16301606 |
| 109 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.00784775 |
| 110 | regulation of plasminogen activation (GO:0010755) | 3.00687755 |
| 111 | metaphase plate congression (GO:0051310) | 2.96028338 |
| 112 | protein deneddylation (GO:0000338) | 2.95908602 |
| 113 | response to redox state (GO:0051775) | 2.87703997 |
| 114 | collagen fibril organization (GO:0030199) | 2.87577621 |
| 115 | piRNA metabolic process (GO:0034587) | 2.86078292 |
| 116 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.78398696 |
| 117 | regulation of female gonad development (GO:2000194) | 2.77765986 |
| 118 | ventricular cardiac muscle cell development (GO:0055015) | 2.71959189 |
| 119 | meiotic cell cycle (GO:0051321) | 2.70994726 |
| 120 | establishment of chromosome localization (GO:0051303) | 2.66911228 |
| 121 | endodermal cell differentiation (GO:0035987) | 2.58409308 |
| 122 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.57834517 |
| 123 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.57291081 |
| 124 | positive regulation of male gonad development (GO:2000020) | 2.56489886 |
| 125 | COPII vesicle coating (GO:0048208) | 2.55942893 |
| 126 | fibrinolysis (GO:0042730) | 2.54383308 |
| 127 | anterior/posterior axis specification, embryo (GO:0008595) | 2.53710316 |
| 128 | chaperone-mediated protein transport (GO:0072321) | 2.49653219 |
| 129 | female gamete generation (GO:0007292) | 2.46874596 |
| 130 | peptidyl-proline hydroxylation (GO:0019511) | 2.45180097 |
| 131 | CENP-A containing nucleosome assembly (GO:0034080) | 2.43536937 |
| 132 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.42210384 |
| 133 | ribosomal large subunit biogenesis (GO:0042273) | 2.41534973 |
| 134 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.41138016 |
| 135 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.38908893 |
| 136 | regulation of acrosome reaction (GO:0060046) | 2.38722540 |
| 137 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.37661676 |
| 138 | paraxial mesoderm development (GO:0048339) | 2.33657643 |
| 139 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.33537938 |
| 140 | termination of RNA polymerase I transcription (GO:0006363) | 2.25892266 |
| 141 | mitotic chromosome condensation (GO:0007076) | 2.25550817 |
| 142 | retinal cone cell development (GO:0046549) | 2.24000086 |
| 143 | chondrocyte proliferation (GO:0035988) | 2.22928000 |
| 144 | oocyte development (GO:0048599) | 2.22791177 |
| 145 | cholesterol efflux (GO:0033344) | 2.22301882 |
| 146 | positive regulation of gastrulation (GO:2000543) | 2.21674705 |
| 147 | cell migration involved in heart development (GO:0060973) | 2.21018102 |
| 148 | tricarboxylic acid cycle (GO:0006099) | 2.20703763 |
| 149 | regulation of spindle organization (GO:0090224) | 2.20479061 |
| 150 | ribosome assembly (GO:0042255) | 2.20196340 |
| 151 | hemidesmosome assembly (GO:0031581) | 2.19501391 |
| 152 | nucleotide transmembrane transport (GO:1901679) | 2.17203173 |
| 153 | chromatin remodeling at centromere (GO:0031055) | 2.15272579 |
| 154 | regulation of cell maturation (GO:1903429) | 2.14961797 |
| 155 | plasma lipoprotein particle assembly (GO:0034377) | 2.14705341 |
| 156 | type B pancreatic cell proliferation (GO:0044342) | 2.13435952 |
| 157 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.13334707 |
| 158 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.13334707 |
| 159 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.13334707 |
| 160 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.13294052 |
| 161 | negative regulation of reproductive process (GO:2000242) | 2.12875751 |
| 162 | female gonad development (GO:0008585) | 2.12816617 |
| 163 | oxidative demethylation (GO:0070989) | 2.11472355 |
| 164 | 7-methylguanosine mRNA capping (GO:0006370) | 2.10772049 |
| 165 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.10574494 |
| 166 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.07398100 |
| 167 | regulation of meiosis (GO:0040020) | 2.06712750 |
| 168 | histone exchange (GO:0043486) | 2.06038624 |
| 169 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.05199947 |
| 170 | binding of sperm to zona pellucida (GO:0007339) | 2.04698382 |
| 171 | synapsis (GO:0007129) | 2.03995400 |
| 172 | doxorubicin metabolic process (GO:0044598) | 2.03942854 |
| 173 | daunorubicin metabolic process (GO:0044597) | 2.03942854 |
| 174 | polyketide metabolic process (GO:0030638) | 2.03942854 |
| 175 | 7-methylguanosine RNA capping (GO:0009452) | 2.03450801 |
| 176 | RNA capping (GO:0036260) | 2.03450801 |
| 177 | positive regulation of meiosis (GO:0045836) | 2.03228556 |
| 178 | primitive streak formation (GO:0090009) | 2.02243535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.16060792 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.99786915 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.50628376 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.25674231 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.10169606 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.84558715 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.58459855 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.80864373 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74663566 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.49258636 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.40983349 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.25466776 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.63677274 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.53110302 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.42764855 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32598697 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.32434984 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.28986787 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18539185 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10066211 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.05984499 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4594675 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.98298824 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95627049 |
| 25 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.90264130 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85074286 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.84158550 |
| 28 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84128313 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.80837549 |
| 30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77387392 |
| 31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.68268366 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.66656223 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62407025 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61719619 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60811890 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.58576832 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.55439159 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54486844 |
| 39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53164350 |
| 40 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.51280689 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.49973002 |
| 42 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.47922789 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47018736 |
| 44 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.46097000 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45698825 |
| 46 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.43110225 |
| 47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.42942394 |
| 48 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.42036159 |
| 49 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38619220 |
| 50 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34587653 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34204700 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33839235 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30897713 |
| 54 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.30004656 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28914762 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28816016 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28499778 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27905221 |
| 59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25753295 |
| 60 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.25013358 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.23347424 |
| 62 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.22908554 |
| 63 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.22021007 |
| 64 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.21982541 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21490237 |
| 66 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20738824 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20583258 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18000827 |
| 69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17519090 |
| 70 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17368205 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15877686 |
| 72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15811127 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15032479 |
| 74 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.14966369 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12800534 |
| 76 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.12786325 |
| 77 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.12595852 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10705123 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10356964 |
| 80 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10119439 |
| 81 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08919471 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08768682 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08115390 |
| 84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07307872 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07163546 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06148938 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05864786 |
| 88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04755848 |
| 89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04755848 |
| 90 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04755848 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03772281 |
| 92 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02483018 |
| 93 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02422470 |
| 94 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00496288 |
| 95 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.00280040 |
| 96 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99165811 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97613621 |
| 98 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97600893 |
| 99 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.97462869 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97317997 |
| 101 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97101666 |
| 102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96335671 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93534023 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93430958 |
| 105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92540240 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91333896 |
| 107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90660066 |
| 108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88712903 |
| 109 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.87540589 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87506067 |
| 111 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87482364 |
| 112 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.87120663 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85568591 |
| 114 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.84442648 |
| 115 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.84425281 |
| 116 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.83186681 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79640269 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79523107 |
| 119 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78257146 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75984265 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74887117 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74296176 |
| 123 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74102614 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73916435 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73098118 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72559594 |
| 127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71862881 |
| 128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71640727 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.71168286 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70616634 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69564448 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69564448 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69249051 |
| 134 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68191093 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67900099 |
| 136 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.66612006 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65797342 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64503332 |
| 139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64474984 |
| 140 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.62724136 |
| 141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62125359 |
| 142 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61578321 |
| 143 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61166690 |
| 144 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59854328 |
| 145 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57952545 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56720452 |
| 147 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.56226924 |
| 148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55928369 |
| 149 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55095055 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54459764 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.53874284 |
| 152 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53806491 |
| 153 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53534875 |
| 154 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53334158 |
| 155 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53242461 |
| 156 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.51359752 |
| 157 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51068702 |
| 158 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51039947 |
| 159 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50955720 |
| 160 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48900468 |
| 161 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48814505 |
| 162 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48413401 |
| 163 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48375291 |
| 164 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47368080 |
| 165 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46939196 |
| 166 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46540401 |
| 167 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46379553 |
| 168 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46090662 |
| 169 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.46053537 |
| 170 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45019388 |
| 171 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44518093 |
| 172 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44361080 |
| 173 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44185872 |
| 174 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.42939319 |
| 175 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42844937 |
| 176 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.42784882 |
| 177 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.42362174 |
| 178 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.42096686 |
| 179 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.41872235 |
| 180 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41645169 |
| 181 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38474521 |
| 182 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.38228665 |
| 183 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.37997137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.09591914 |
| 2 | MP0005360_urolithiasis | 7.91798923 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.94682025 |
| 4 | MP0005365_abnormal_bile_salt | 5.81898378 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05770522 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 4.23513673 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.98916210 |
| 8 | MP0003252_abnormal_bile_duct | 3.84544713 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.43216607 |
| 10 | MP0005332_abnormal_amino_acid | 3.42550710 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.21592604 |
| 12 | MP0003195_calcinosis | 3.20714015 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.97843594 |
| 14 | MP0003941_abnormal_skin_development | 2.90740616 |
| 15 | MP0005503_abnormal_tendon_morphology | 2.72278351 |
| 16 | MP0009840_abnormal_foam_cell | 2.68827897 |
| 17 | MP0010030_abnormal_orbit_morphology | 2.67720131 |
| 18 | MP0005275_abnormal_skin_tensile | 2.56825095 |
| 19 | MP0004272_abnormal_basement_membrane | 2.54925415 |
| 20 | MP0005083_abnormal_biliary_tract | 2.51795626 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.47202830 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.41151932 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.00382422 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.00339052 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.95572057 |
| 26 | MP0000609_abnormal_liver_physiology | 1.95176729 |
| 27 | MP0000762_abnormal_tongue_morphology | 1.94730372 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.88564947 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.83974305 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.83796339 |
| 31 | MP0001764_abnormal_homeostasis | 1.76540183 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.70874691 |
| 33 | MP0003868_abnormal_feces_composition | 1.70444570 |
| 34 | MP0002234_abnormal_pharynx_morphology | 1.62993058 |
| 35 | MP0003186_abnormal_redox_activity | 1.62554831 |
| 36 | MP0000751_myopathy | 1.60254258 |
| 37 | MP0000749_muscle_degeneration | 1.58609500 |
| 38 | MP0003011_delayed_dark_adaptation | 1.56738362 |
| 39 | MP0009250_abnormal_appendicular_skeleto | 1.56702376 |
| 40 | MP0005451_abnormal_body_composition | 1.55130357 |
| 41 | MP0006054_spinal_hemorrhage | 1.55075383 |
| 42 | MP0005023_abnormal_wound_healing | 1.47689224 |
| 43 | MP0008932_abnormal_embryonic_tissue | 1.43363096 |
| 44 | MP0004043_abnormal_pH_regulation | 1.42646969 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.41104167 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.39527371 |
| 47 | MP0001299_abnormal_eye_distance/ | 1.33181304 |
| 48 | MP0005623_abnormal_meninges_morphology | 1.32728495 |
| 49 | MP0009697_abnormal_copulation | 1.28983965 |
| 50 | MP0008058_abnormal_DNA_repair | 1.26622271 |
| 51 | MP0003077_abnormal_cell_cycle | 1.23901870 |
| 52 | MP0005508_abnormal_skeleton_morphology | 1.23325333 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.22727330 |
| 54 | MP0002108_abnormal_muscle_morphology | 1.22724426 |
| 55 | MP0003385_abnormal_body_wall | 1.21378492 |
| 56 | MP0002233_abnormal_nose_morphology | 1.21041789 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 1.19538383 |
| 58 | MP0003755_abnormal_palate_morphology | 1.18020824 |
| 59 | MP0000733_abnormal_muscle_development | 1.17712842 |
| 60 | MP0001756_abnormal_urination | 1.16082710 |
| 61 | MP0003693_abnormal_embryo_hatching | 1.15383311 |
| 62 | MP0002160_abnormal_reproductive_system | 1.15145510 |
| 63 | MP0005171_absent_coat_pigmentation | 1.14443523 |
| 64 | MP0000598_abnormal_liver_morphology | 1.11167569 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.09406294 |
| 66 | MP0002295_abnormal_pulmonary_circulatio | 1.09206196 |
| 67 | MP0003279_aneurysm | 1.08211576 |
| 68 | MP0005670_abnormal_white_adipose | 1.08077167 |
| 69 | MP0009764_decreased_sensitivity_to | 1.07817943 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 1.06783716 |
| 71 | MP0005394_taste/olfaction_phenotype | 1.02396286 |
| 72 | MP0005499_abnormal_olfactory_system | 1.02396286 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 1.02222690 |
| 74 | MP0001542_abnormal_bone_strength | 1.01719277 |
| 75 | MP0004084_abnormal_cardiac_muscle | 0.99611548 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.99181947 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.98191764 |
| 78 | MP0005647_abnormal_sex_gland | 0.97781581 |
| 79 | MP0003879_abnormal_hair_cell | 0.97252512 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.96566914 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.94408222 |
| 82 | MP0003937_abnormal_limbs/digits/tail_de | 0.93608766 |
| 83 | MP0002060_abnormal_skin_morphology | 0.92977669 |
| 84 | MP0002269_muscular_atrophy | 0.92263339 |
| 85 | MP0000049_abnormal_middle_ear | 0.91603323 |
| 86 | MP0002938_white_spotting | 0.91576799 |
| 87 | MP0001293_anophthalmia | 0.91521498 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.89983381 |
| 89 | MP0000604_amyloidosis | 0.89937957 |
| 90 | MP0003136_yellow_coat_color | 0.89252843 |
| 91 | MP0000759_abnormal_skeletal_muscle | 0.87852725 |
| 92 | MP0010094_abnormal_chromosome_stability | 0.86935961 |
| 93 | MP0009763_increased_sensitivity_to | 0.86558854 |
| 94 | MP0005535_abnormal_body_temperature | 0.86548268 |
| 95 | MP0003111_abnormal_nucleus_morphology | 0.86249756 |
| 96 | MP0008469_abnormal_protein_level | 0.86025701 |
| 97 | MP0005410_abnormal_fertilization | 0.85768509 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.85613684 |
| 99 | MP0002697_abnormal_eye_size | 0.81175388 |
| 100 | MP0005408_hypopigmentation | 0.80767394 |
| 101 | MP0003699_abnormal_female_reproductive | 0.80189508 |
| 102 | MP0010386_abnormal_urinary_bladder | 0.79986075 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.79591269 |
| 104 | MP0003935_abnormal_craniofacial_develop | 0.79100913 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.78835510 |
| 106 | MP0004145_abnormal_muscle_electrophysio | 0.78018902 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.76239825 |
| 108 | MP0005220_abnormal_exocrine_pancreas | 0.75923391 |
| 109 | MP0005187_abnormal_penis_morphology | 0.75870210 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.75421631 |
| 111 | MP0001929_abnormal_gametogenesis | 0.73592346 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.72901332 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.72824448 |
| 114 | MP0002210_abnormal_sex_determination | 0.72166776 |
| 115 | MP0002971_abnormal_brown_adipose | 0.70234362 |
| 116 | MP0002928_abnormal_bile_duct | 0.70004886 |
| 117 | MP0001730_embryonic_growth_arrest | 0.69157431 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.68278635 |
| 119 | MP0003890_abnormal_embryonic-extraembry | 0.67616109 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.67311894 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.66943683 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.66551399 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.66475405 |
| 124 | MP0003329_amyloid_beta_deposits | 0.66179183 |
| 125 | MP0001915_intracranial_hemorrhage | 0.65989153 |
| 126 | MP0000653_abnormal_sex_gland | 0.65831218 |
| 127 | MP0005334_abnormal_fat_pad | 0.65776438 |
| 128 | MP0002254_reproductive_system_inflammat | 0.65251795 |
| 129 | MP0001661_extended_life_span | 0.65179255 |
| 130 | MP0010368_abnormal_lymphatic_system | 0.64332930 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.62844662 |
| 132 | MP0005330_cardiomyopathy | 0.62806260 |
| 133 | MP0002085_abnormal_embryonic_tissue | 0.62486550 |
| 134 | MP0004130_abnormal_muscle_cell | 0.62039912 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.61870076 |
| 136 | MP0005266_abnormal_metabolism | 0.57954714 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.57284033 |
| 138 | MP0003690_abnormal_glial_cell | 0.57273831 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.55813933 |
| 140 | MP0002168_other_aberrant_phenotype | 0.55428591 |
| 141 | MP0005395_other_phenotype | 0.53274440 |
| 142 | MP0003953_abnormal_hormone_level | 0.46964230 |
| 143 | MP0000538_abnormal_urinary_bladder | 0.46795533 |
| 144 | MP0003724_increased_susceptibility_to | 0.45843213 |
| 145 | MP0005448_abnormal_energy_balance | 0.43643099 |
| 146 | MP0003075_altered_response_to | 0.41863058 |
| 147 | MP0000639_abnormal_adrenal_gland | 0.41096471 |
| 148 | MP0002135_abnormal_kidney_morphology | 0.40660883 |
| 149 | MP0005166_decreased_susceptibility_to | 0.40352600 |
| 150 | MP0008874_decreased_physiological_sensi | 0.40180545 |
| 151 | MP0005464_abnormal_platelet_physiology | 0.38912025 |
| 152 | MP0008872_abnormal_physiological_respon | 0.37618305 |
| 153 | MP0002796_impaired_skin_barrier | 0.37313981 |
| 154 | MP0008961_abnormal_basal_metabolism | 0.37139991 |
| 155 | MP0004782_abnormal_surfactant_physiolog | 0.37051885 |
| 156 | MP0009115_abnormal_fat_cell | 0.35593758 |
| 157 | MP0004147_increased_porphyrin_level | 0.34817113 |
| 158 | MP0008873_increased_physiological_sensi | 0.33566442 |
| 159 | MP0003300_gastrointestinal_ulcer | 0.33444540 |
| 160 | MP0003959_abnormal_lean_body | 0.33439479 |
| 161 | MP0009053_abnormal_anal_canal | 0.32249305 |
| 162 | MP0001958_emphysema | 0.31316402 |
| 163 | MP0009672_abnormal_birth_weight | 0.30043233 |
| 164 | MP0002970_abnormal_white_adipose | 0.29671817 |
| 165 | MP0009384_cardiac_valve_regurgitation | 0.29481208 |
| 166 | MP0004264_abnormal_extraembryonic_tissu | 0.29417107 |
| 167 | MP0003718_maternal_effect | 0.29392999 |
| 168 | MP0002837_dystrophic_cardiac_calcinosis | 0.29294017 |
| 169 | MP0001845_abnormal_inflammatory_respons | 0.28531788 |
| 170 | MP0001944_abnormal_pancreas_morphology | 0.27864265 |
| 171 | MP0000249_abnormal_blood_vessel | 0.26244944 |
| 172 | MP0005595_abnormal_vascular_smooth | 0.25504670 |
| 173 | MP0001853_heart_inflammation | 0.24075837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.69671760 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.37128892 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.98367576 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.72262889 |
| 5 | Xanthomatosis (HP:0000991) | 5.57428422 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.12806003 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.12083435 |
| 8 | Hyperglycinuria (HP:0003108) | 4.90894777 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.76260759 |
| 10 | Ketosis (HP:0001946) | 4.73327843 |
| 11 | Hyperammonemia (HP:0001987) | 4.62080288 |
| 12 | Hyperglycinemia (HP:0002154) | 4.59873781 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.57989951 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.57989951 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.57444166 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.29660152 |
| 17 | Complement deficiency (HP:0004431) | 4.25101888 |
| 18 | Premature rupture of membranes (HP:0001788) | 4.21401162 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20839833 |
| 20 | Gout (HP:0001997) | 4.15679817 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.01032121 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.96449870 |
| 23 | Ketoacidosis (HP:0001993) | 3.93953724 |
| 24 | Joint hemorrhage (HP:0005261) | 3.91325177 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.85935281 |
| 26 | Epidermoid cyst (HP:0200040) | 3.79731808 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.71616548 |
| 28 | Fat malabsorption (HP:0002630) | 3.71427225 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.65721150 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.61991399 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.60969212 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.57844455 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.55633831 |
| 34 | Protrusio acetabuli (HP:0003179) | 3.55005683 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.43528501 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.39674542 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39410230 |
| 38 | Popliteal pterygium (HP:0009756) | 3.37071544 |
| 39 | Generalized aminoaciduria (HP:0002909) | 3.29061260 |
| 40 | Supernumerary spleens (HP:0009799) | 3.25192506 |
| 41 | Proximal tubulopathy (HP:0000114) | 3.21712910 |
| 42 | Vascular calcification (HP:0004934) | 3.17124697 |
| 43 | Hyperuricemia (HP:0002149) | 3.16068729 |
| 44 | Increased purine levels (HP:0004368) | 3.16068729 |
| 45 | Metabolic acidosis (HP:0001942) | 3.13580090 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.12850689 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 3.11452370 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 3.06108330 |
| 49 | Hyperbilirubinemia (HP:0002904) | 3.05899502 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.04300432 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 3.04300432 |
| 52 | Abnormality of placental membranes (HP:0011409) | 3.02737911 |
| 53 | Amniotic constriction ring (HP:0009775) | 3.02737911 |
| 54 | Ankle contracture (HP:0006466) | 3.02170863 |
| 55 | Abnormality of complement system (HP:0005339) | 3.01557362 |
| 56 | Lethargy (HP:0001254) | 2.93782966 |
| 57 | Hypercholesterolemia (HP:0003124) | 2.93346439 |
| 58 | Alkalosis (HP:0001948) | 2.90398712 |
| 59 | Osteomalacia (HP:0002749) | 2.85431285 |
| 60 | Steatorrhea (HP:0002570) | 2.84015863 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.82332504 |
| 62 | Follicular hyperkeratosis (HP:0007502) | 2.77138563 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.71499802 |
| 64 | Aortic dissection (HP:0002647) | 2.68724408 |
| 65 | Neonatal short-limb short stature (HP:0008921) | 2.66714504 |
| 66 | Glycosuria (HP:0003076) | 2.64664963 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.64664963 |
| 68 | Soft skin (HP:0000977) | 2.59084269 |
| 69 | Cerebral edema (HP:0002181) | 2.52232318 |
| 70 | Malnutrition (HP:0004395) | 2.51198545 |
| 71 | Vomiting (HP:0002013) | 2.49190592 |
| 72 | Enlarged kidneys (HP:0000105) | 2.47937678 |
| 73 | Irritability (HP:0000737) | 2.44198101 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.42971313 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 2.41765043 |
| 76 | Wrist flexion contracture (HP:0001239) | 2.41521342 |
| 77 | Atrophic scars (HP:0001075) | 2.40594600 |
| 78 | Nemaline bodies (HP:0003798) | 2.40186568 |
| 79 | Spastic diplegia (HP:0001264) | 2.40017153 |
| 80 | Neonatal onset (HP:0003623) | 2.38190831 |
| 81 | Rickets (HP:0002748) | 2.35996203 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 2.35628434 |
| 83 | Hydroxyprolinuria (HP:0003080) | 2.35628434 |
| 84 | Myocardial infarction (HP:0001658) | 2.34903042 |
| 85 | Aortic aneurysm (HP:0004942) | 2.34790025 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.30080485 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.27708536 |
| 88 | Hypokalemic alkalosis (HP:0001949) | 2.26784152 |
| 89 | Vascular tortuosity (HP:0004948) | 2.26524487 |
| 90 | Aplasia of the musculature (HP:0100854) | 2.26122588 |
| 91 | Septo-optic dysplasia (HP:0100842) | 2.25373813 |
| 92 | Late onset (HP:0003584) | 2.24307822 |
| 93 | Pterygium (HP:0001059) | 2.24277488 |
| 94 | Skin nodule (HP:0200036) | 2.23221821 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 2.22501451 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.21744492 |
| 97 | Pancreatitis (HP:0001733) | 2.18829466 |
| 98 | Abnormal delivery (HP:0001787) | 2.17000792 |
| 99 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.16531277 |
| 100 | Mitral stenosis (HP:0001718) | 2.14659760 |
| 101 | Spontaneous abortion (HP:0005268) | 2.14225177 |
| 102 | Muscle fiber inclusion bodies (HP:0100299) | 2.13842243 |
| 103 | Increased circulating renin level (HP:0000848) | 2.12490512 |
| 104 | Abnormality of dentin (HP:0010299) | 2.11734468 |
| 105 | Hyperactive renin-angiotensin system (HP:0000841) | 2.10327564 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.08187810 |
| 107 | Renal cortical cysts (HP:0000803) | 2.05984422 |
| 108 | Microglossia (HP:0000171) | 2.05944137 |
| 109 | Stillbirth (HP:0003826) | 2.05760454 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 2.04659024 |
| 111 | Nephrolithiasis (HP:0000787) | 2.04249756 |
| 112 | Brushfield spots (HP:0001088) | 2.03181339 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 2.02918386 |
| 114 | Abnormality of glycolysis (HP:0004366) | 2.02157880 |
| 115 | Cholelithiasis (HP:0001081) | 2.01502666 |
| 116 | Abnormal urine output (HP:0012590) | 2.00677682 |
| 117 | Opisthotonus (HP:0002179) | 1.98824063 |
| 118 | Hypophosphatemic rickets (HP:0004912) | 1.98466733 |
| 119 | Acanthocytosis (HP:0001927) | 1.98204530 |
| 120 | Hip contracture (HP:0003273) | 1.97553124 |
| 121 | Metabolic alkalosis (HP:0200114) | 1.97353591 |
| 122 | Limited hip movement (HP:0008800) | 1.96972578 |
| 123 | Natal tooth (HP:0000695) | 1.96952535 |
| 124 | Short tibia (HP:0005736) | 1.96668734 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 1.96572219 |
| 126 | Cholecystitis (HP:0001082) | 1.96572219 |
| 127 | Confusion (HP:0001289) | 1.95578344 |
| 128 | Esophageal varix (HP:0002040) | 1.94889104 |
| 129 | Hyperphosphaturia (HP:0003109) | 1.94467365 |
| 130 | Exercise-induced muscle cramps (HP:0003710) | 1.94131030 |
| 131 | Entropion (HP:0000621) | 1.92675058 |
| 132 | Abnormality of renal excretion (HP:0011036) | 1.92092631 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.91737172 |
| 134 | Type I transferrin isoform profile (HP:0003642) | 1.91439995 |
| 135 | Facial cleft (HP:0002006) | 1.91417123 |
| 136 | Nausea (HP:0002018) | 1.90417768 |
| 137 | Abnormal cartilage morphology (HP:0002763) | 1.89252271 |
| 138 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.89098692 |
| 139 | Delayed gross motor development (HP:0002194) | 1.88862506 |
| 140 | Wormian bones (HP:0002645) | 1.88364336 |
| 141 | Fragile skin (HP:0001030) | 1.88135053 |
| 142 | Shallow orbits (HP:0000586) | 1.85994849 |
| 143 | Knee flexion contracture (HP:0006380) | 1.85342768 |
| 144 | Absent septum pellucidum (HP:0001331) | 1.85093382 |
| 145 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.84795935 |
| 146 | Arterial tortuosity (HP:0005116) | 1.84408234 |
| 147 | Cervical subluxation (HP:0003308) | 1.84356942 |
| 148 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83688504 |
| 149 | Spondylolisthesis (HP:0003302) | 1.80864950 |
| 150 | Abnormality of carpal bone ossification (HP:0006257) | 1.75933911 |
| 151 | Renal tubular dysfunction (HP:0000124) | 1.75762453 |
| 152 | Coronal craniosynostosis (HP:0004440) | 1.70137724 |
| 153 | Bladder diverticulum (HP:0000015) | 1.69481313 |
| 154 | Abnormality of the septum pellucidum (HP:0007375) | 1.69027596 |
| 155 | Median cleft lip (HP:0000161) | 1.65616786 |
| 156 | Abnormal protein glycosylation (HP:0012346) | 1.64371028 |
| 157 | Abnormal glycosylation (HP:0012345) | 1.64371028 |
| 158 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.64371028 |
| 159 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.64371028 |
| 160 | Muscle stiffness (HP:0003552) | 1.63688689 |
| 161 | Breech presentation (HP:0001623) | 1.63672334 |
| 162 | Abnormality of the acetabulum (HP:0003170) | 1.62601816 |
| 163 | Methylmalonic acidemia (HP:0002912) | 1.62240986 |
| 164 | Abnormal urine phosphate concentration (HP:0012599) | 1.62070234 |
| 165 | Azoospermia (HP:0000027) | 1.61585941 |
| 166 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.60561814 |
| 167 | Bifid tongue (HP:0010297) | 1.58977605 |
| 168 | Neoplasm of head and neck (HP:0012288) | 1.58597082 |
| 169 | Esophageal neoplasm (HP:0100751) | 1.58597082 |
| 170 | Sparse eyelashes (HP:0000653) | 1.57449567 |
| 171 | Elbow flexion contracture (HP:0002987) | 1.56382979 |
| 172 | Renal Fanconi syndrome (HP:0001994) | 1.55802222 |
| 173 | Femoral bowing (HP:0002980) | 1.55098756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.21352366 |
| 2 | FGFR4 | 3.97961060 |
| 3 | WNK3 | 3.78202495 |
| 4 | WNK4 | 3.62740680 |
| 5 | SIK1 | 3.54031924 |
| 6 | ERN1 | 3.49025854 |
| 7 | PBK | 3.19276303 |
| 8 | OXSR1 | 3.02321363 |
| 9 | EIF2AK3 | 2.80267131 |
| 10 | BUB1 | 2.72207797 |
| 11 | INSRR | 2.65319360 |
| 12 | ARAF | 2.46558347 |
| 13 | TAOK3 | 2.37265170 |
| 14 | STK16 | 2.33762369 |
| 15 | TTK | 2.25417742 |
| 16 | ERBB4 | 2.24543498 |
| 17 | MAP3K12 | 2.07983930 |
| 18 | MST1R | 2.02657613 |
| 19 | OBSCN | 1.93954821 |
| 20 | TNIK | 1.82704972 |
| 21 | MAP2K4 | 1.80165144 |
| 22 | MAPK11 | 1.73794165 |
| 23 | PTK6 | 1.71795513 |
| 24 | PKN2 | 1.70364872 |
| 25 | STK38L | 1.69296507 |
| 26 | MAP3K9 | 1.64010793 |
| 27 | SRPK1 | 1.62096470 |
| 28 | TIE1 | 1.55106875 |
| 29 | CDK9 | 1.54108768 |
| 30 | LIMK1 | 1.53739137 |
| 31 | PIK3CG | 1.53300658 |
| 32 | MST4 | 1.49881628 |
| 33 | MUSK | 1.44676911 |
| 34 | PDGFRA | 1.43605974 |
| 35 | NEK9 | 1.43298549 |
| 36 | STK24 | 1.42136459 |
| 37 | MAP3K7 | 1.40973345 |
| 38 | TRIB3 | 1.40756615 |
| 39 | ABL2 | 1.40150557 |
| 40 | EIF2AK1 | 1.39580977 |
| 41 | NEK6 | 1.38322659 |
| 42 | PINK1 | 1.37991751 |
| 43 | MOS | 1.35855398 |
| 44 | PAK2 | 1.35079674 |
| 45 | FRK | 1.34682437 |
| 46 | LATS2 | 1.32604671 |
| 47 | EPHB2 | 1.32186327 |
| 48 | BRAF | 1.29683627 |
| 49 | PAK4 | 1.29453023 |
| 50 | FLT3 | 1.27553661 |
| 51 | LATS1 | 1.27052019 |
| 52 | PLK3 | 1.24269264 |
| 53 | CDK8 | 1.23278776 |
| 54 | FGFR2 | 1.22185185 |
| 55 | NME1 | 1.22133322 |
| 56 | STK39 | 1.21443873 |
| 57 | NUAK1 | 1.16983214 |
| 58 | CDK19 | 1.16173085 |
| 59 | TYK2 | 1.15826568 |
| 60 | SGK223 | 1.13951941 |
| 61 | SGK494 | 1.13951941 |
| 62 | BMPR1B | 1.10529725 |
| 63 | DDR2 | 1.09472132 |
| 64 | CDC7 | 1.09394693 |
| 65 | SGK3 | 1.08072739 |
| 66 | STK3 | 1.07578753 |
| 67 | ILK | 1.07032684 |
| 68 | PRKAA2 | 1.05987509 |
| 69 | MAPK15 | 1.05671314 |
| 70 | ZAK | 1.04206754 |
| 71 | PLK1 | 1.03762443 |
| 72 | PDK4 | 1.03698854 |
| 73 | PDK3 | 1.03698854 |
| 74 | PIM2 | 1.02472765 |
| 75 | RAF1 | 1.01553825 |
| 76 | BRSK2 | 0.98952053 |
| 77 | JAK2 | 0.98111896 |
| 78 | KDR | 0.97995747 |
| 79 | GRK6 | 0.95072937 |
| 80 | MAP4K2 | 0.93497151 |
| 81 | CDK7 | 0.93168291 |
| 82 | MAP3K13 | 0.92121839 |
| 83 | DAPK2 | 0.90902784 |
| 84 | TGFBR1 | 0.89007766 |
| 85 | MAP2K3 | 0.88109907 |
| 86 | TGFBR2 | 0.87800396 |
| 87 | AURKA | 0.87293700 |
| 88 | SGK2 | 0.87258618 |
| 89 | DMPK | 0.85499998 |
| 90 | AKT3 | 0.83557408 |
| 91 | PRKCI | 0.82927604 |
| 92 | IRAK3 | 0.82725713 |
| 93 | RIPK1 | 0.80774354 |
| 94 | PRKCZ | 0.80698366 |
| 95 | MAP3K3 | 0.79264861 |
| 96 | MAPK4 | 0.79094463 |
| 97 | TBK1 | 0.78720460 |
| 98 | VRK1 | 0.77503710 |
| 99 | EPHB1 | 0.76294502 |
| 100 | MAP3K11 | 0.75809951 |
| 101 | PRKAA1 | 0.75428923 |
| 102 | GSK3A | 0.75390786 |
| 103 | DYRK1B | 0.73300143 |
| 104 | MAP3K14 | 0.72731999 |
| 105 | NTRK1 | 0.70607082 |
| 106 | PDPK1 | 0.69754247 |
| 107 | TRIM28 | 0.69423738 |
| 108 | AURKB | 0.69078579 |
| 109 | PHKG1 | 0.67029454 |
| 110 | PHKG2 | 0.67029454 |
| 111 | STK38 | 0.67012826 |
| 112 | MAPK12 | 0.65518768 |
| 113 | PRKACG | 0.64285633 |
| 114 | JAK1 | 0.63945082 |
| 115 | PTK2 | 0.63700836 |
| 116 | PLK4 | 0.63092644 |
| 117 | NEK2 | 0.62913802 |
| 118 | LMTK2 | 0.61359981 |
| 119 | VRK2 | 0.61018390 |
| 120 | ERBB2 | 0.60939997 |
| 121 | BRSK1 | 0.60541105 |
| 122 | PLK2 | 0.58943033 |
| 123 | PNCK | 0.58885296 |
| 124 | ROCK1 | 0.58808568 |
| 125 | LRRK2 | 0.57221935 |
| 126 | MAP2K6 | 0.56362440 |
| 127 | RPS6KB2 | 0.54279835 |
| 128 | NEK1 | 0.54056845 |
| 129 | CAMK2G | 0.52770404 |
| 130 | PDK2 | 0.52558113 |
| 131 | PRKCQ | 0.52530061 |
| 132 | MKNK2 | 0.52392189 |
| 133 | MET | 0.51448060 |
| 134 | PDK1 | 0.51180140 |
| 135 | AKT2 | 0.51129960 |
| 136 | WEE1 | 0.50379187 |
| 137 | CHEK2 | 0.49858360 |
| 138 | CHEK1 | 0.48677095 |
| 139 | RET | 0.48582872 |
| 140 | ROCK2 | 0.47808514 |
| 141 | CAMK1D | 0.47773435 |
| 142 | CSK | 0.47569254 |
| 143 | FER | 0.46161938 |
| 144 | PRKG1 | 0.45677401 |
| 145 | IGF1R | 0.45493781 |
| 146 | CDK6 | 0.45129217 |
| 147 | EPHA2 | 0.44754187 |
| 148 | MAP3K5 | 0.44265360 |
| 149 | KSR2 | 0.43720617 |
| 150 | TTN | 0.43453949 |
| 151 | DAPK3 | 0.43155919 |
| 152 | ERBB3 | 0.41940881 |
| 153 | CSNK2A2 | 0.41611075 |
| 154 | BCR | 0.41366038 |
| 155 | CASK | 0.40884625 |
| 156 | MYLK | 0.39268947 |
| 157 | FGFR3 | 0.37510028 |
| 158 | MAP2K1 | 0.36705648 |
| 159 | CSNK1G1 | 0.33774874 |
| 160 | KIT | 0.33772008 |
| 161 | MAPK7 | 0.32284567 |
| 162 | EPHA3 | 0.31840268 |
| 163 | EPHA4 | 0.31572352 |
| 164 | MAP3K10 | 0.30927941 |
| 165 | IKBKE | 0.30496794 |
| 166 | PRKCA | 0.27749412 |
| 167 | PRKCG | 0.26877376 |
| 168 | PRKG2 | 0.26626185 |
| 169 | CSF1R | 0.24485842 |
| 170 | MAP3K6 | 0.24293573 |
| 171 | FGFR1 | 0.22942861 |
| 172 | MTOR | 0.20985858 |
| 173 | PIK3CA | 0.20575410 |
| 174 | CAMK4 | 0.19764068 |
| 175 | MAP4K1 | 0.19717441 |
| 176 | MAP2K2 | 0.18891237 |
| 177 | IRAK2 | 0.18642867 |
| 178 | PAK3 | 0.18397137 |
| 179 | MAP3K1 | 0.17661185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06177605 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.46219929 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15156780 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01500013 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82116447 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.76257261 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74658561 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71969616 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70294638 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69819114 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.58943818 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.56020352 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49059032 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.39658040 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.33249551 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 2.25350557 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18847275 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99444574 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99365031 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97715285 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.92179183 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90084990 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.89648724 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87216428 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.86368947 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.85985440 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.83860604 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80737023 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78456924 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77490601 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75418543 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74482301 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65517634 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63224431 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61787286 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61481846 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58833137 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.57864210 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55590356 |
| 40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.54947223 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49880459 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48551205 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47043919 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 1.45911896 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42508854 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40638554 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38575360 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31908133 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.31436524 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31132188 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29390375 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.26344529 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26181232 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26086525 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25994993 |
| 56 | Cell cycle_Homo sapiens_hsa04110 | 1.22716116 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 1.20033307 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19998638 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19579151 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17128148 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14876715 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14826838 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 1.06581843 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06491576 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04488226 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.99859176 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97238850 |
| 68 | RNA transport_Homo sapiens_hsa03013 | 0.96272659 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96244334 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95080346 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94686332 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.93625446 |
| 73 | DNA replication_Homo sapiens_hsa03030 | 0.92555707 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91783488 |
| 75 | Base excision repair_Homo sapiens_hsa03410 | 0.91711705 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90248096 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89225615 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86503369 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83879757 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83682342 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82831610 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79640356 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77394990 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76965405 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76102215 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.72567866 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72131883 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68539159 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66645380 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66059575 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65606306 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65010999 |
| 93 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60052145 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59377857 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57310086 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56862590 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56654343 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54630703 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52027360 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.48817841 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47409797 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.46913053 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44780893 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39154205 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28593069 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26363724 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.23436107 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20694226 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18617722 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18259367 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.16296773 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15287767 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11303689 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08241215 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02256573 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01843825 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01682570 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01099978 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.2203529 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2059909 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1998051 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1977336 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | -0.1750795 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1498357 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1337390 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1312119 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1222990 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1182134 |
| 129 | Lysosome_Homo sapiens_hsa04142 | -0.1034786 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0863190 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0826221 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0698038 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | -0.0438297 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0344010 |
| 135 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0218287 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0123241 |

